{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:42:48Z","timestamp":1792204968247,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Villa Joep Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ejca.2016.12.002","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T07:34:29Z","timestamp":1483688069000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients"],"prefix":"10.1016","volume":"72","author":[{"given":"Iedan R.N.","family":"Verly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 B.P.","family":"van Kuilenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico G.G.M.","family":"Abeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.I.","family":"Goorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric M.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max M.","family":"van Noesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michel","family":"Zwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GertJan L.","family":"Kaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.M.","family":"Merks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib N.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godelieve A.M.","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2016.12.002_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hoc.2009.11.011","article-title":"Neuroblastoma: biology, prognosis, and treatment","volume":"24","author":"Park","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"10.1016\/j.ejca.2016.12.002_bib2","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2016.12.002_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/1096-911X(200008)35:2<153::AID-MPO18>3.0.CO;2-7","article-title":"False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma","volume":"35","author":"Biasotti","year":"2000","journal-title":"Med Pediatr Oncol"},{"issue":"23","key":"10.1016\/j.ejca.2016.12.002_bib4","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejca.2016.12.002_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/1097-0142(197101)27:1<228::AID-CNCR2820270132>3.0.CO;2-F","article-title":"Significance of catecholamine excretion in the follow-up of sympathoblastomas","volume":"27","author":"Barontini de","year":"1971","journal-title":"Cancer"},{"issue":"Pt 1","key":"10.1016\/j.ejca.2016.12.002_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1258\/000456304322664663","article-title":"Measurement of catecholamines and their metabolites","volume":"41","author":"Peaston","year":"2004","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"10.1016\/j.ejca.2016.12.002_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/pbc.20888","article-title":"Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients","volume":"48","author":"Strenger","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2016.12.002_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/mpo.2950200306","article-title":"Methylated catecholamine metabolites for diagnosis of neuroblastoma","volume":"20","author":"Candito","year":"1992","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2016.12.002_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/1097-0142(19830301)51:5<834::AID-CNCR2820510515>3.0.CO;2-#","article-title":"Tumor and urine catecholamines (CATs) in neurogenic tumors. Correlations with other prognostic factors and survival","volume":"51","author":"Graham-Pole","year":"1983","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2016.12.002_bib10","first-page":"43","article-title":"Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma","volume":"107","author":"Nakagawara","year":"1990","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.ejca.2016.12.002_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s10024001-0145-8","article-title":"Hormonal activity may predict aggressive behavior in neuroblastoma","volume":"5","author":"Zambrano","year":"2002","journal-title":"Pediatr Dev Pathol"},{"issue":"10","key":"10.1016\/j.ejca.2016.12.002_bib12","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/clinchem\/36.10.1834","article-title":"Simultaneous determination of acidic 3, 4-dihydroxyphenylalanine metabolites and 5-hydroxyindole-3-acetic acid in urine by high-performance liquid chromatography","volume":"36","author":"Stroomer","year":"1990","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.ejca.2016.12.002_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0009-8981(84)90181-5","article-title":"Simultaneous determination of catecholamines and metanephrines in urine by HPLC with fluorometric detection","volume":"137","author":"Abeling","year":"1984","journal-title":"Clin Chim Acta"},{"issue":"Pt 4","key":"10.1016\/j.ejca.2016.12.002_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1258\/acb.2011.011023","article-title":"Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children","volume":"48","author":"Davidson","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ejca.2016.12.002_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/0004563216654723","article-title":"Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers","author":"Lam","year":"2016","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"10.1016\/j.ejca.2016.12.002_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/jnci\/57.3.633","article-title":"Catecholamine metabolism in neuroblastoma","volume":"57","author":"LaBrosse","year":"1976","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.ejca.2016.12.002_bib17","first-page":"1995","article-title":"Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors","volume":"40","author":"LaBrosse","year":"1980","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ejca.2016.12.002_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2265.2009.03761.x","article-title":"Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasma","volume":"73","author":"Deutschbein","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ejca.2016.12.002_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(76)80725-1","article-title":"Effect of diet on urinary excretion of VMA, HVA, metanephrine, and total free catecholamine in normal preschool children","volume":"88","author":"Weetman","year":"1976","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.ejca.2016.12.002_bib20","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1097-0142(20010515)91:10<1905::AID-CNCR1213>3.0.CO;2-4","article-title":"Metabolic activity and clinical features of primary ganglioneuromas","volume":"91","author":"Geoerger","year":"2001","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2016.12.002_bib21","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1200\/JCO.2003.07.142","article-title":"Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy","volume":"21","author":"Kushner","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2016.12.002_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/pbc.21035","article-title":"The prognostic role of urinary catecholamines in infants with disseminated neuroblastoma may be mediated by MYCN amplification","volume":"48","author":"Parodi","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2016.12.002_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1542\/peds.62.1.77","article-title":"Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma","volume":"62","author":"Laug","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejca.2016.12.002_bib24","first-page":"417","article-title":"Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma","volume":"5","author":"Cangemi","year":"2012","journal-title":"Onco Targets Ther"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916330696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916330696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:25:16Z","timestamp":1718987116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804916330696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":24,"alternative-id":["S0959804916330696"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.12.002","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}